A
Akitaka Shibuya
Researcher at Kitasato University
Publications - 113
Citations - 2621
Akitaka Shibuya is an academic researcher from Kitasato University. The author has contributed to research in topics: Hepatocellular carcinoma & Cirrhosis. The author has an hindex of 26, co-authored 111 publications receiving 2376 citations. Previous affiliations of Akitaka Shibuya include Tosoh.
Papers
More filters
Journal ArticleDOI
Radiofrequency Ablation of Hepatocellular Carcinoma: Correlation Between Local Tumor Progression After Ablation and Ablative Margin
Takahide Nakazawa,Shigehiro Kokubu,Akitaka Shibuya,Koji Ono,Masaaki Watanabe,Hisashi Hidaka,Takeshi Tsuchihashi,Katsunori Saigenji +7 more
TL;DR: An ablation zone with an ablative margin of 5 mm or greater was the most important factor for local control of hepatocellular carcinoma after radiofrequency ablation.
Journal ArticleDOI
Evidence-based clinical practice guidelines for liver cirrhosis 2015
Hiroshi Fukui,Hidetsugu Saito,Yoshiyuki Ueno,Hirofumi Uto,Katsutoshi Obara,Isao Sakaida,Akitaka Shibuya,Masataka Seike,Sumiko Nagoshi,Makoto Segawa,Hirohito Tsubouchi,Hisataka Moriwaki,Akinobu Kato,Etsuko Hashimoto,Kojiro Michitaka,Toshikazu Murawaki,Kentaro Sugano,Mamoru Watanabe,Tooru Shimosegawa +18 more
TL;DR: The Japanese Society of Gastroenterology revised the evidence-based clinical practice guidelines for liver cirrhosis in 2015 with use of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system and introduces selected clinical questions and statements related to the management of liver Cirrhosis and its complications.
Journal ArticleDOI
Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis
Akitaka Shibuya,Katsuaki Tanaka,Hiroshi Miyakawa,Minoru Shibata,Masao Takatori,Kazuhiko Sekiyama,Naoaki Hashimoto,Shuuichi Amaki,Tatsuji Komatsu,Toshio Morizane +9 more
TL;DR: HCC develops in old patients with advanced‐stage PBC, but HCC does not affect the patients' survival, and 3 factors are independently associated with the development of HCC: age at the time of diagnosis, male gender, and history of blood transfusion.
Journal ArticleDOI
An Autopsy Case of Troglitazone-Induced Fulminant Hepatitis
Akitaka Shibuya,Masaaki Watanabe,Yoshikuni Fujita,Katsunori Saigenji,Sadahito Kuwao,Hisao Takahashi,Haruo Takeuchi +6 more
TL;DR: The present case indicates that troglitazone can induce hypersensitivity resulting in fulminant hepatitis and careful monitoring of serum liver enzymes during trog litazone therapy is therefore essential.
Journal ArticleDOI
Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
Takahide Nakazawa,Hisashi Hidaka,Akitaka Shibuya,Yusuke Okuwaki,Yoshiaki Tanaka,Juichi Takada,Tsutomu Minamino,Masaaki Watanabe,Shigehiro Kokubu,Wasaburo Koizumi +9 more
TL;DR: RT is a better first-line therapy than sorafenib in patients who have advanced unresectable HCC with PVTT and portal vein tumor thrombosis in the main trunk or the first branch.